Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06636097

Intaglio Surface of Full-arch Implant Supported Prosthesis

Effect of the Intaglio Surface of Full-arch Implant-supported on Marginal Bone Level: A Cross-sectional Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to determine if there is an association between the intaglio shape of full-arch implant-supported prosthesis and marginal bone level around implants. The intaglio shape can be present as concave or convex and, depending on that, it can lead to more plaque accumulation on the fitting surface of the prosthesis. Null Hypothesis (H0): Full-arch implant supported prosthesis with an increased depth of the intaglio shape demonstrate similar marginal bone levels as prosthesis with a reduced depth of the intaglio surface. Alternative Hypothesis (H1): Full-arch implant supported prosthesis with an increased depth of the intaglio shape demonstrate increased/reduced marginal bone levels compared to prosthesis with a reduced depth of the intaglio surface.

Detailed description

The investigators will review dental records from the university and call eligible individuals for an appointment. During the research visit, the investigators will take new x-rays for marginal bone level assessment and a digital scan of the prosthesis to assess the shape of the intaglio. Also, remove the prosthesis, perform clinical measurements and collect plaque samples from the prosthesis and the implant sulcus. then, implants and prosthesis will be cleaned and placed in position. The study will have only one appointment where every measurement will be assessed in this visit.

Conditions

Interventions

TypeNameDescription
DEVICEFull archdesign

Timeline

Start date
2024-06-11
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2024-10-10
Last updated
2025-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06636097. Inclusion in this directory is not an endorsement.